Immunofluorescence microscopy analyses revealed that treatment with AC484 increased the frequency of tumour-infiltrating CD45+ and CD8+ cells in B16 and KPC tumours, comparable to changes elicited by anti-PD-1 (Fig. 4a,b and Extended Data Fig. 4a,b). The gene discussed is PTPRC; the disease is neoplasm.